106 studies found for:    "Cone-rod dystrophy"
Show Display Options
Rank Status Study
1 Recruiting Inherited Retinal Degenerative Disease Registry
Conditions: Eye Diseases Hereditary;   Retinal Disease;   Achromatopsia;   Bardet-Biedl Syndrome;   Bassen-Kornzweig Syndrome;   Batten Disease;   Best Disease;   Choroidal Dystrophy;   Choroideremia;   Cone Dystrophy;   Cone-Rod Dystrophy;   Congenital Stationary Night Blindness;   Enhanced S-Cone Syndrome;   Fundus Albipunctatus;   Goldmann-Favre Syndrome;   Gyrate Atrophy;   Juvenile Macular Degeneration;   Kearns-Sayre Syndrome;   Leber Congenital Amaurosis;   Refsum Syndrome;   Retinitis Pigmentosa;   Retinitis Punctata Albescens;   Retinoschisis;   Rod-Cone Dystrophy;   Rod Dystrophy;   Rod Monochromacy;   Stargardt Disease;   Usher Syndrome
Intervention:
2 Active, not recruiting A Dose Ranging Study to Evaluate the Safety and Potential Efficacy of rhNGF in Patients With Retinitis Pigmentosa (RP)
Condition: Retinitis Pigmentosa
Interventions: Drug: rhNGF 60 µg/ml eye drops solution;   Drug: rhNGF 180 µg/ml eye drops solution;   Drug: Placebo
3 Terminated A Study to Evaluate the Safety of CNTO 2476 in Patients With Advanced Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Drug: CNTO 2476
4 Recruiting Study of UshStat in Patients With Retinitis Pigmentosa Associated With Usher Syndrome Type 1B
Conditions: Usher Syndrome;   Retinitis Pigmentosa
Intervention: Genetic: UshStat
5 Recruiting Cone Rescue in Retinitis Pigmentosa by the Treatment of Lycium Barbarum
Condition: Retinitis Pigmentosa
Interventions: Dietary Supplement: Lycium Barbarum;   Dietary Supplement: Placebo
6 Completed Stress and Vision Fluctuations in Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention:
7 Recruiting Studying a Potential Protective Effect of L-Dopa on Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Drug: levodopa-carbidopa
8 Completed Safety Study in Retinal Transplantation for Retinitis Pigmentosa.
Condition: Retinitis Pigmentosa.
Interventions: Device: Retinal transplantation instrument;   Device: Fetal tissue.
9 Completed Acupuncture for the Treatment of Vision Loss Due to Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Procedure: Electro-acupuncture
10 Completed
Has Results
Clinical Trial of Lutein for Patients With Retinitis Pigmentosa Receiving Vitamin A
Condition: Retinitis Pigmentosa
Interventions: Drug: Lutein;   Dietary Supplement: Cornstarch control
11 Completed Trial of Oral Valproic Acid for Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Interventions: Drug: Valproic Acid;   Drug: Placebo
12 Recruiting RST-001 Phase I/II Trial for Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Drug: RST-001
13 Completed Investigating the Effect of Vitamin A Supplementation on Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Drug: Vitamin A
14 Completed Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Biological: intravitreal injection of autologous bone marrow stem cells
15 Completed Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Biological: intravitreal injection of autologous bone marrow stem cells
16 Recruiting Clinical Implication of Retinitis Pigmentosa Molecular Diagnostic Using High Throughput Sequencing.
Condition: Retinitis Pigmentosa
Intervention:
17 Active, not recruiting Electro-acupuncture and Transcorneal Electrical Stimulation (TES) for the Treatment of Vision Loss Due to Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Interventions: Device: Electro-acupuncture;   Device: Laser Acupuncture;   Device: Transcorneal Electrical Stimulation;   Device: Sham Electro-acupuncture;   Device: Sham laser acupuncture;   Device: Sham transcorneal electrical stimulation
18 Active, not recruiting Study of Oral Minocycline in Treating Bilateral Cystoid Macular Edema Associated With Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Drug: Minocycline
19 Recruiting Clinical Characterization on PDE6A-related Retinitis Pigmentosa in Preparation to a Gene Therapy Trial
Condition: Retinitis Pigmentosa
Intervention:
20 Not yet recruiting Clinical Trials of Continuous Oxygen Therapy Combined With Blue Light Deprivation in the Treatment of Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Interventions: Drug: Continuous oxygen;   Device: blue light-absorbing sunglasses;   Drug: Compound thrombosis capsule sig: 1.5g/tid;   Drug: Ginkgo biloba pills sig: 300mg/tid;;   Drug: Vitamin B sig: 10mg/tid;   Drug: Vitamin AD sig: 1 tablet/tid

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years